SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-055706
Filing Date
2024-05-08
Accepted
2024-05-08 16:18:42
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q srzn-20240331.htm   iXBRL 10-Q 1777552
2 EX-10.1 srzn-ex10_1.htm EX-10.1 147686
3 EX-31.1 srzn-ex31_1.htm EX-31.1 15014
4 EX-31.2 srzn-ex31_2.htm EX-31.2 15073
5 EX-32.1 srzn-ex32_1.htm EX-32.1 8373
6 EX-32.2 srzn-ex32_2.htm EX-32.2 8411
7 GRAPHIC img200698715_0.jpg GRAPHIC 35774
  Complete submission text file 0000950170-24-055706.txt   7332235

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT srzn-20240331.xsd EX-101.SCH 1227220
69 EXTRACTED XBRL INSTANCE DOCUMENT srzn-20240331_htm.xml XML 1045867
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

IRS No.: 301374889 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39635 | Film No.: 24926379
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)